There are 2789 resources available
744P - Use of PARPi among patients with advanced ovarian cancer: Results from a real-world database
Presenter: Shaheenah Dawood
Session: ePoster Display
746P - Real-world clinical outcomes of patients with de novo advanced high-grade epithelial ovarian cancer eligible to niraparib maintenance in France
Presenter: Manuel Rodrigues
Session: ePoster Display
747P - Real-world experience of rucaparib in patients with ovarian cancer: A multicentre United Kingdom study
Presenter: Mark Lythgoe
Session: ePoster Display
748P - Real-world-data (RWD) on platinum (Pt)-based chemotherapy (CT) after PARP inhibitors (PARPi) in high-grade serous (or endometrioid) ovarian cancer (HGSEOC)
Presenter: Margarita Romeo Marin
Session: ePoster Display
877P - Comparison of dosimetric benefits in nasopharyngeal carcinoma patients among intensity-modulated radiotherapy, volumetric-modulated arc therapy and tomotherapy
Presenter: Wei Xiong
Session: ePoster Display
878P - Clinical profile and treatment outcomes of locally advanced carcinoma larynx treated with organ preservation approach: A retrospective analysis
Presenter: Afsar Fasaludeen
Session: ePoster Display
879P - Adaptive radiotherapy in head and neck cancer: A prospective dosimetric and volumetric study
Presenter: Apurva Pandey
Session: ePoster Display
880P - Systematic literature review (SLR) of randomized controlled trials in patients (pts) with newly diagnosed locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
Presenter: Karthik Ramakrishnan
Session: ePoster Display
881P - Impact of neck dissection in N2-3 oropharyngeal squamous-cell carcinomas treated with definitive chemo-radiotherapy: An observational real-life study
Presenter: Guillaume Klausner
Session: ePoster Display